UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Design and implementation of a randomized controlled social and mobile weight loss trial for young adults (project SMART)

Contemporary clinical trials, 2014-01, Vol.37 (1), p.10-18

2014

Volltextzugriff (PDF)

The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer’s Disease (TRC-PAD) Project: An Overview

The Journal of Prevention of Alzheimer's Disease, 2020, Vol.7 (4), p.208-212

2020

Volltextzugriff (PDF)

Sensitivity of the Preclinical Alzheimer’s Cognitive Composite (PACC), PACC5, and Repeatable Battery for Neuropsychological Status (RBANS) to Amyloid Status in Preclinical Alzheimer’s Disease -Atabecestat Phase 2b/3 EARLY Clinical Trial

The Journal Of Prevention of Alzheimer's Disease, 2022, Vol.9 (2), p.255-261

2022

Volltextzugriff (PDF)

The relative efficiency of time-to-threshold and rate of change in longitudinal data

Contemporary clinical trials, 2011-09, Vol.32 (5), p.685-693

2011

Volltextzugriff (PDF)

Emerging β-amyloid pathology and accelerated cortical atrophy

JAMA neurology, 2014-06, Vol.71 (6), p.725

2014

Volltextzugriff (PDF)

Natural cubic splines for the analysis of Alzheimer's clinical trials

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2023-05, Vol.22 (3), p.508-519

2023

Volltextzugriff (PDF)

Defining the Optimal Target Population for Trials of Polyunsaturated Fatty Acid Supplementation Using the Erythrocyte Omega-3 Index: A Step Towards Personalized Prevention of Cognitive Decline?

The Journal of nutrition, health & aging, 2018-10, Vol.22 (8), p.982-988

2018

Volltextzugriff (PDF)

The Computerized Cognitive Composite (C3) in A4, an Alzheimer’s Disease Secondary Prevention Trial

The Journal of Prevention of Alzheimer's Disease, 2021-01, Vol.8 (1), p.59-67

2021

Volltextzugriff (PDF)

Predicting Amyloid Burden to Accelerate Recruitment of Secondary Prevention Clinical Trials

The Journal of Prevention of Alzheimer's Disease, 2020, Vol.7 (4), p.213-218

2020

Volltextzugriff (PDF)

Change in Digital Cognitive Test Performance between Solanezumab and Placebo Groups in Preclinical Alzheimer’s Disease: Secondary Analyses from the A4 Study

The Journal of Prevention of Alzheimer's Disease, 2024, Vol.11 (4), p.846-856

2024

Volltextzugriff (PDF)

Longitudinal Trajectories of the Cognitive Function Index in the A4 Study

The Journal of Prevention of Alzheimer's Disease, 2024, Vol.11 (4), p.838-845

2024

Volltextzugriff (PDF)

Characterizing Clinical Progression in Cognitively Unimpaired Older Individuals with Brain Amyloid: Results from the A4 Study

The Journal of Prevention of Alzheimer's Disease, 2024, Vol.11 (4), p.814-822

2024

Volltextzugriff (PDF)

Maximizing the Utility of Alzheimer’s Disease Trial Data: Sharing of Baseline A4 and LEARN Data

The Journal of Prevention of Alzheimer's Disease, 2024, Vol.11 (4), p.889-894

2024

Volltextzugriff (PDF)

Greater White Matter Hyperintensity Volume Is Associated with the Number of Microhemorrhages in Preclinical Alzheimer’s Disease

The Journal of Prevention of Alzheimer's Disease, 2024, Vol.11 (4), p.869-873

2024

Volltextzugriff (PDF)

Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies

The Journal of Prevention of Alzheimer's Disease, 2024, Vol.11 (4), p.802-813

2024

Volltextzugriff (PDF)

Longitudinal Phospho-tau217 Predicts Amyloid Positron Emission Tomography in Asymptomatic Alzheimer’s Disease

The Journal of Prevention of Alzheimer's Disease, 2024, Vol.11 (4), p.823-830

2024

Volltextzugriff (PDF)

Pre-Randomization Predictors of Study Discontinuation in a Preclinical Alzheimer’s Disease Randomized Controlled Trial

The Journal of Prevention of Alzheimer's Disease, 2024, Vol.11 (4), p.874-880

2024

Volltextzugriff (PDF)

Item-Level Investigation of Participant and Study Partner Report on the Cognitive Function Index from the A4 Study Screening Data

The Journal Of Prevention of Alzheimer's Disease, 2021, Vol.8 (3), p.257-262

2021

Volltextzugriff (PDF)

A randomized, triple-masked, active-controlled investigation of the relative effects of dose, concentration, and infusion rate for continuous popliteal-sciatic nerve blocks in volunteers

British journal of anaesthesia : BJA, 2015-01, Vol.114 (1), p.121-129

2015

Volltextzugriff (PDF)

Left Frontoparietal Control Network Connectivity Moderates the Effect of Amyloid on Cognitive Decline in Preclinical Alzheimer’s Disease: The A4 Study

The Journal of Prevention of Alzheimer's Disease, 2024, Vol.11 (4), p.881-888

2024

Volltextzugriff (PDF)

Mixed model of repeated measures versus slope models in Alzheimer’s disease clinical trials

The Journal of nutrition, health & aging, 2012-04, Vol.16 (4), p.360-364

2012

Volltextzugriff (PDF)

Amyloid-Related Imaging Abnormalities and Other MRI Findings in a Cognitively Unimpaired Population With and Without Cerebral Amyloid

The Journal Of Prevention of Alzheimer's Disease, 2022, Vol.9 (4), p.617-624

2022

Volltextzugriff (PDF)

Shape parameters and the density dependence of hard-chain equations of state

AIChE journal, 1992-05, Vol.38 (5), p.788-792

1992

Volltextzugriff (PDF)

Age-related synapse loss in hippocampal CA3 is not reversed by caloric restriction

Neuroscience, 2010-12, Vol.171 (2), p.373-382

2010

Volltextzugriff (PDF)

The limit of viability — Neonatal outcome of infants bora at 22 to 25 weeks' gestation

International journal of gynecology and obstetrics, 1994-09, Vol.46 (3), p.355-356

1994

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(26)
Tagungsberichte
(1)

Sprache

Englisch
(27)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Design and implementation of a randomized controlled social and mobile weight loss trial for young adults (project SMART)

The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer’s Disease (TRC-PAD) Project: An Overview

Sensitivity of the Preclinical Alzheimer’s Cognitive Composite (PACC), PACC5, and Repeatable Battery for Neuropsychological Status (RBANS) to Amyloid Status in Preclinical Alzheimer’s Disease -Atabecestat Phase 2b/3 EARLY Clinical Trial

The relative efficiency of time-to-threshold and rate of change in longitudinal data

Emerging β-amyloid pathology and accelerated cortical atrophy

Natural cubic splines for the analysis of Alzheimer's clinical trials

Defining the Optimal Target Population for Trials of Polyunsaturated Fatty Acid Supplementation Using the Erythrocyte Omega-3 Index: A Step Towards Personalized Prevention of Cognitive Decline?

The Computerized Cognitive Composite (C3) in A4, an Alzheimer’s Disease Secondary Prevention Trial

Predicting Amyloid Burden to Accelerate Recruitment of Secondary Prevention Clinical Trials

Change in Digital Cognitive Test Performance between Solanezumab and Placebo Groups in Preclinical Alzheimer’s Disease: Secondary Analyses from the A4 Study

Longitudinal Trajectories of the Cognitive Function Index in the A4 Study

Characterizing Clinical Progression in Cognitively Unimpaired Older Individuals with Brain Amyloid: Results from the A4 Study

Maximizing the Utility of Alzheimer’s Disease Trial Data: Sharing of Baseline A4 and LEARN Data

Greater White Matter Hyperintensity Volume Is Associated with the Number of Microhemorrhages in Preclinical Alzheimer’s Disease

Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies

Longitudinal Phospho-tau217 Predicts Amyloid Positron Emission Tomography in Asymptomatic Alzheimer’s Disease

Pre-Randomization Predictors of Study Discontinuation in a Preclinical Alzheimer’s Disease Randomized Controlled Trial

Item-Level Investigation of Participant and Study Partner Report on the Cognitive Function Index from the A4 Study Screening Data

A randomized, triple-masked, active-controlled investigation of the relative effects of dose, concentration, and infusion rate for continuous popliteal-sciatic nerve blocks in volunteers

Left Frontoparietal Control Network Connectivity Moderates the Effect of Amyloid on Cognitive Decline in Preclinical Alzheimer’s Disease: The A4 Study

Mixed model of repeated measures versus slope models in Alzheimer’s disease clinical trials

Amyloid-Related Imaging Abnormalities and Other MRI Findings in a Cognitively Unimpaired Population With and Without Cerebral Amyloid

Shape parameters and the density dependence of hard-chain equations of state

Age-related synapse loss in hippocampal CA3 is not reversed by caloric restriction

The limit of viability — Neonatal outcome of infants bora at 22 to 25 weeks' gestation

Suchergebnisse filtern